Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Type I interferons may help treat skin issues in lupus and dermatomyositis.

Calancardin B may help reduce inflammation in immune cells.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

DFMO may help control hair growth and treat cancer.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Restoring hair follicle immune privilege may help treat alopecia areata.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

Alopecia areata involves unique activation of certain immune cells.